Home/Pipeline/BSV-001

BSV-001

Dengue (all serotypes)

PreclinicalActive

Key Facts

Indication
Dengue (all serotypes)
Phase
Preclinical
Status
Active
Company

About Kimer Med

Kimer Med builds modular, host‑targeted biologics to deliver broad‑spectrum antivirals for pandemic‑ready therapeutics.

View full company profile

Therapeutic Areas